$66.99 $1.67 per serving
Product analysis
BCQ combines boswellia and turmeric with bromelain and quercetin for possible joint-comfort support. Preparation-specific evidence limits expectations of a broader effect on everyday inflammation or digestion.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality32
Boswellia acid types and turmeric curcuminoids are named. Missing boswellia proportions and unspecified bromelain and quercetin preparations limit a close quality comparison.
Ingredient Transparency65
The individual ingredient amounts are stated. Some preparation details and the boswellia source proportions are missing, limiting comparisons with specific extracts.
Value For Money27
The turmeric and bromelain contributions are relatively costly. Boswellia and quercetin lack a reliable value comparison to establish whether the wider blend offsets those costs.
Customer Satisfaction75
Customer ratings are positive across a moderate number of entries. They offer some context for satisfaction without proving effects on joint comfort or digestion.
Product Focus68
The compact ingredient mix has a possible connection to joint comfort. Its broader digestive and inflammation-related uses remain uncertain because effects depend on particular preparations.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $1.67
- Also available
BCQ$102.90- Customer rating
- 4.5 · 828 ratings
Goals
Impact
Moderate effect
Boswellia · 600 mg
Boswellia
How this product is rated for Inflammation
Ingredient fit78
Several nutrients and other actives serve broader purposes; their presence does not imply a separate anti-inflammatory effect. Declared amounts describe one label serving.
Goal fit
Several nutrients and other actives serve broader purposes; their presence does not imply a separate anti-inflammatory effect.
Dose adequacy
The selected serving declares Turmeric 600 mg, Quercetin 300 mg, Boswellia 600 mg.
Pathways18
The ingredients relate most closely to enzymes involved in inflammatory signalling. These roles do not guarantee symptom relief.
Depth
The ingredients relate most closely to enzymes involved in inflammatory signalling.
Breadth
These connections describe possible biological roles, rather than confirming a broad reduction in inflammation.
Evidence44
Generic Boswellia cannot be assumed equivalent to specific extracts linked to knee osteoarthritis symptom relief. Turmeric, Boswellia do not identify the specific preparation needed to transfer its effects directly.
Evidence strength
Generic Boswellia cannot be assumed equivalent to specific extracts linked to knee osteoarthritis symptom relief.
Studied preparation
Turmeric, Boswellia do not identify the specific preparation needed to transfer its effects directly.
Formulation logic92
Turmeric lacks its absorption partner, which limits confidence in transferring effects from other preparations. No particular ingredient conflict is identified.
Partner coverage
Turmeric lacks its absorption partner, which limits confidence in transferring effects from other preparations.
Conflicts
No particular ingredient conflict is identified.
Effective doses
The declared amounts provide a basis for comparison, without showing that the serving will produce an anti-inflammatory benefit.
Impact
Moderate effect
Boswellia · 600 mg
Boswellia and turmeric relate to inflammation and joint comfort, with findings that depend on particular extracts. The 600 mg amounts of each provide the main botanical contribution, while bromelain adds an inflammation-related angle with uncertain benefit from its joint trials.
How this product is rated for Joint Health
Ingredient fit75
The relevant ingredients are closely joint healthed on the goal. The assessed quantities provide a meaningful but incomplete match to the saved benchmarks.
Goal fit
The relevant ingredients are closely joint healthed on the goal.
Dose adequacy
The assessed quantities provide a meaningful but incomplete match to the saved benchmarks.
Pathways48
The main recorded contribution relates to inflammation and joint comfort. Cartilage-related support forms a smaller contribution. One main mechanism meets the saved coverage benchmark, so support is relatively jointed.
Depth
The main recorded contribution relates to inflammation and joint comfort. Cartilage-related support forms a smaller contribution.
Breadth
One main mechanism meets the saved coverage benchmark, so support is relatively jointed.
Evidence43
Bromelain provides the strongest evidence contribution among the assessed ingredients. Bromelain matches a studied preparation in the saved assessment; boswellia and turmeric do not.
Evidence strength
Bromelain provides the strongest evidence contribution among the assessed ingredients.
Studied preparation
Bromelain matches a studied preparation in the saved assessment; boswellia and turmeric do not.
Formulation logic100
The assessed ingredients can contribute independently or have their required partners. No ingredient conflict was flagged by the saved checks.
Partner coverage
The assessed ingredients can contribute independently or have their required partners.
Conflicts
No ingredient conflict was flagged by the saved checks.
Effective doses
All counted ingredients meet the saved minimum amount threshold.
Impact
Highest effect
Bromelain · 300 mgBoswellia · 600 mg
Bromelain breaks down protein, but its enzyme activity does not establish relief of digestive symptoms. Boswellia receives a saved contribution, although the supplied clinical context does not establish routine digestive benefit from this preparation. The turmeric extract cannot inherit the functional-dyspepsia findings for rhizome powder. The formula therefore has narrower and less certain practical digestive relevance than its inflammation-related saved findings might suggest.
How this product is rated for Gut Health
Ingredient fit80
The formula includes digestive-related ingredients, but preparation and clinical-context limitations affect their practical meaning.
Goal fit
The saved contributions focus on boswellia and bromelain; quercetin serves other purposes and the turmeric extract lacks transferable preparation support.
Dose adequacy
Boswellia and bromelain are well represented by amount in the saved findings, without establishing routine digestive efficacy.
Pathways77
The saved findings emphasize inflammation-related and enzyme-related routes, without establishing routine symptom relief.
Depth
The strongest saved finding concerns inflammation-related pathways, but the clinical context does not establish routine inflammation treatment.
Breadth
Inflammation-related and enzyme-related routes are represented, without established benefits across stool regulation, nausea or other digestive symptoms.
Evidence81
The strongest saved evidence finding needs to be read alongside ingredient-specific preparation and population limitations.
Evidence strength
Boswellia leads the saved evidence finding, though the supplied clinical context does not establish routine digestive symptom benefit.
Studied preparation
The saved finding recognizes boswellia and bromelain preparations; this does not resolve the limitations of their digestive symptom evidence.
Formulation logic100
The counted ingredients need no missing required partner, and no evaluated conflict is identified.
Partner coverage
The counted ingredients can contribute without an additional required partner.
Conflicts
No evaluated ingredient conflict is identified in the supplied facts.
Effective doses
All counted ingredients meet the saved amount requirement; this is not a demonstrated minimum effective dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Boswellia serrata gum extract (Alpha Boswellic Acid, Beta Boswellic Acid) | 600 mg | |
Bromelain | 300 mg | |
Curcuma longa rhizome extract (Total Curcuminoids) | 600 mg | |
Quercetin Dihydrate | 300 mg |
Each serving provides 600 mg of boswellia gum extract. The saved facts do not provide its boswellic-acid percentage, leaving the marker concentration unknown.
How this ingredient is rated
Composition and Label Disclosure0
The saved facts do not provide a boswellic-acid percentage for the boswellia preparation.
Marker and Preparation Disclosure
The saved facts do not provide a boswellic-acid percentage for the boswellia preparation.
Composition and Label Disclosure60
The serving amount and source are disclosed as 600 mg of boswellia gum extract.
Boswellia Amount and Marker Disclosure
The serving amount and source are disclosed as 600 mg of boswellia gum extract.
Commercial Price and Usability
Price was not evaluated for boswellia.
Bromelain · 300 mg OverallScore43
Turmeric (Total Curcuminoids) · 600 mg OverallScore6
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Positive Effects of a Lecithin-Based Delivery Form of Boswellia serrata Extract in Acute Diarrhea of Adult Subjects.
- Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.
- Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome.
- Interventions for treating collagenous colitis.
- Interventions for treating collagenous colitis.
- The role of enzyme supplementation in digestive disorders.
- Effects of bromelain supplementation on disease activity and quality of life in patients with ulcerative colitis: a randomized, triple-blind, placebo-controlled study.
- Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
- A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
- Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
- A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
- A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
- Therapeutic efficacy of bromelain in impacted third molar surgery: a randomized controlled clinical study.
- Efficacy of proteolytic enzyme bromelain on health outcomes after third molar surgery. Systematic review and meta-analysis of randomized clinical trials.
- Placebo-controlled randomized clinical trial on the immunomodulating activities of low- and high-dose bromelain after oral administration - new evidence on the antiinflammatory mode of action of bromelain.
- An Evaluation of the Effects of Pineapple-Extract and Bromelain-Based Treatment after Mandibular Third Molar Surgery: A Randomized Three-Arm Clinical Study.
- Therapeutic uses of pineapple-extracted bromelain in surgical care - A review.
- Oral herbal therapies for treating osteoarthritis.
- Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
- A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.